Critical Structural Defects Explain Filamin A Mutations Causing Mitral Valve Dysplasia.
Ontology highlight
ABSTRACT: Mitral valve diseases affect ∼3% of the population and are the most common reasons for valvular surgery because no drug-based treatments exist. Inheritable genetic mutations have now been established as the cause of mitral valve insufficiency, and four different missense mutations in the filamin A gene (FLNA) have been found in patients suffering from nonsyndromic mitral valve dysplasia (MVD). The filamin A (FLNA) protein is expressed, in particular, in endocardial endothelia during fetal valve morphogenesis and is key in cardiac development. The FLNA-MVD-causing mutations are clustered in the N-terminal region of FLNA. How the mutations in FLNA modify its structure and function has mostly remained elusive. In this study, using NMR spectroscopy and interaction assays, we investigated FLNA-
SUBMITTER: Haataja TJK
PROVIDER: S-EPMC6817519 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA